Eosinophil paradox with mepolizumab in chronic rhinosinusitis with nasal polyposis

被引:4
|
作者
Lipworth, Brian [1 ]
Chan, Rory [1 ]
Kuo, Chris RuiWen [1 ]
机构
[1] Univ Dundee, Scottish Ctr Resp Res, Dundee, Scotland
关键词
ASTHMA;
D O I
10.1016/j.jaci.2020.05.054
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:683 / 683
页数:1
相关论文
共 50 条
  • [1] Mepolizumab in chronic rhinosinusitis with nasal polyposis
    Liu, Xuandao
    Charn, Tze Choong
    Wang, De-Yun
    IMMUNOTHERAPY, 2023, 15 (14) : 1105 - 1116
  • [2] Mepolizumab for chronic rhinosinusitis with nasal polyps
    Brusselle, Guy G.
    Gevaert, Philippe
    LANCET RESPIRATORY MEDICINE, 2021, 9 (10): : 1081 - 1082
  • [3] Documentation of biological therapies in chronic rhinosinusitis with nasal polyposis (CRSwNP): dupilumab, omalizumab and mepolizumab
    Klimek, Ludger
    Foerster-Ruhrmann, Ulrike
    Beule, Achim G.
    Chaker, Adam M.
    Hagemann, Jan
    Klimek, Felix
    Casper, Ingrid
    Huppertz, Tilman
    Hoffmann, Thomas K.
    Dazert, Stefan
    Deitmer, Thomas
    Olze, Heidi
    Strieth, Sebastian
    Wrede, Holger
    Schlenter, Wolfgang
    Welkoborsky, Hans-Juergen
    Wollenberg, Barbara
    Bergmann, Christoph
    Cuevas, Mandy
    Beutner, Caroline
    Groeger, Moritz
    Becker, Sven
    ALLERGO JOURNAL, 2022, 31 (06) : 24 - 38
  • [4] Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count
    Bachert, Claus
    Sousa, Ana R.
    Han, Joseph K.
    Schlosser, Rodney J.
    Sowerby, Leigh J.
    Hopkins, Claire
    Maspero, Jorge F.
    Smith, Steven G.
    Kante, Oliver
    Karidi-Andrioti, Despina E.
    Mayer, Bhabita
    Chan, Robert H.
    Yancey, Steve W.
    Chaker, Adam M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (05) : 1711 - +
  • [5] Mepolizumab response in severe chronic rhinosinusitis with nasal polyps is dissociated from blood eosinophil levels
    Lipworth, Brian
    Chan, Rory
    Misirovs, Rasads
    Stewart, Kirsten
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (05) : 1817 - 1817
  • [6] Nasal expression of the vascular endothelial growth factor and its receptors is reduced by mepolizumab in chronic rhinosinusitis with nasal polyposis
    Cavaliere, Carlo
    Masieri, Simonetta
    Greco, Antonio
    Lambiase, Alessandro
    Segatto, Marco
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (04) : 442 - 443
  • [7] Refractory Chronic Rhinosinusitis with Nasal Polyposis
    Hull, Benjamin P.
    Chandra, Rakesh K.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2017, 50 (01) : 61 - +
  • [8] Inflammation in Chronic Rhinosinusitis and Nasal Polyposis
    van Drunen, Cornelis M.
    Reinartz, Susanne
    Wigman, Jochem
    Fokkens, Wytske J.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2009, 29 (04) : 621 - +
  • [9] Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis
    Schleimer, Robert P.
    ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 12, 2017, 12 : 331 - 357
  • [10] Biologics in chronic rhinosinusitis with nasal polyposis
    Laidlaw, Tanya M.
    Buchheit, Kathleen M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 124 (04) : 326 - 332